Graham Capital Management L.P. Acquires 4,533 Shares of Encompass Health Corporation $EHC

Graham Capital Management L.P. raised its holdings in Encompass Health Corporation (NYSE:EHC) by 12.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 40,283 shares of the company’s stock after acquiring an additional 4,533 shares during the quarter. Graham Capital Management L.P.’s holdings in Encompass Health were worth $4,080,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. WPG Advisers LLC bought a new position in shares of Encompass Health in the 1st quarter worth $27,000. Colonial Trust Co SC acquired a new position in Encompass Health in the fourth quarter valued at about $29,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after buying an additional 367 shares during the last quarter. Arlington Trust Co LLC grew its position in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company’s stock worth $68,000 after buying an additional 125 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its stake in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after acquiring an additional 115 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Down 1.4%

Shares of EHC stock opened at $121.71 on Monday. Encompass Health Corporation has a 12-month low of $87.85 and a 12-month high of $124.67. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. The firm has a fifty day moving average of $116.66 and a 200-day moving average of $111.22. The company has a market capitalization of $12.26 billion, a price-to-earnings ratio of 23.82, a P/E/G ratio of 2.13 and a beta of 0.92.

Encompass Health (NYSE:EHC) last announced its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.20 by $0.20. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, equities research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.19 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health’s payout ratio is presently 14.87%.

Insider Buying and Selling

In related news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on EHC shares. Wall Street Zen lowered shares of Encompass Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 6th. KeyCorp lifted their price target on shares of Encompass Health from $122.00 to $135.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 27th. UBS Group upped their price objective on shares of Encompass Health from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Stephens raised Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price objective on the stock in a research note on Thursday, June 5th. Finally, Truist Financial boosted their target price on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $134.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.